Translator Disclaimer
1 January 2009 Experimental Infection of Richardson's Ground Squirrels (Spermophilus richardsonii) with Attenuated and Virulent Strains of Brucella abortus
Author Affiliations +
Abstract

A previous investigation of the safety of Brucella abortus strain RB51 (sRB51) in various nontarget species suggested that Richardson's ground squirrels (Spermophilus richardsonii) may develop persistent infections when orally inoculated with the vaccine. In the present study, sRB51, B. abortus strain 19 (s19), and virulent B. abortus strain 9941 (s9941) were administered orally to Richardson's ground squirrels to further characterize B. abortus infection in this species. Six groups of nongravid ground squirrels were orally inoculated with 6×108 colony forming units (cfu) sRB51 (n=10), 2.5×104 cfu s19 (n=10), 2.5×107 cfu s19 (n=6), 1.3×106 cfu s9941 (n=5), 2.1×108 cfu s9941 (n=5), or vaccine diluent (control; n=4). One of five animals in the lower-dose s19 group and two of three animals in the higher-dose s19 group showed persistence of bacteria in various tissues at 14 wk postinoculation (PI). At 18 wk PI, one of five animals in the sRB51 group and one of five animals in the high-dose s9941 group were culture positive. Although we did detect some persistence of B. abortus strains at 18 wk, we found no evidence of pathology caused by B. abortus strains in nonpregnant Richardson's ground squirrels based on clinical signs, gross lesions, and microscopic lesions.

Nol, Olsen, and Rhyan: Experimental Infection of Richardson's Ground Squirrels (Spermophilus richardsonii) with Attenuated and Virulent Strains of Brucella abortus
Pauline Nol, Steven C. Olsen, and Jack C. Rhyan "Experimental Infection of Richardson's Ground Squirrels (Spermophilus richardsonii) with Attenuated and Virulent Strains of Brucella abortus," Journal of Wildlife Diseases 45(1), 189-195, (1 January 2009). https://doi.org/10.7589/0090-3558-45.1.189
Received: 25 October 2007; Published: 1 January 2009
JOURNAL ARTICLE
7 PAGES


SHARE
ARTICLE IMPACT
Back to Top